2015 Utah Code
Title 58 - Occupations and Professions
Chapter 37 - Utah Controlled Substances Act
Section 4.2 - Listed controlled substances.

Effective 3/20/2014
58-37-4.2. Listed controlled substances.
The following substances, their analogs, homologs, and synthetic equivalents are listed controlled substances:

• (1) AB-001;

• (2) AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;

• (3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;

• (4) AKB48;

• (5) alpha-Pyrrolidinovalerophenone (alpha-PVP);

• (6) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;

• (7) AM-1248;

• (8) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;

• (9) AM-2233;

• (10) AM-679;

• (11) A796,260;

• (12) Butylone;

• (13) CP 47,497 and its C6, C8, and C9 homologs; 2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;

• (14) Diisopropyltryptamine (DiPT);

• (15) Ethylone;

• (16) Ethylphenidate;

• (17) Fluoroisocathinone;

• (18) Fluoromethamphetamine;

• (19) Fluoromethcathinone;

• (20) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

• (21) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

• (22) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;

• (23) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};

• (24) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;

• (25) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};

• (26) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;

• (27) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);

• (28) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

• (29) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;

• (30) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;

• (31) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;

• (32) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;

• (33) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

• (34) MAM-2201;

• (35) MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;

• (36) Methoxetamine;

• (37) Naphyrone;

• (38) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;

• (39) Pentedrone;

• (40) Pentylone;

• (41) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;

• (42) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};

• (43) STS-135;

• (44) UR-144;

• (45) UR-144 N-(5-chloropentyl) analog;

• (46) XLR11;

• (47) 2C-C;

• (48) 2C-D;

• (49) 2C-E;

• (50) 2C-H;

• (51) 2C-I;

• (52) 2C-N;

• (53) 2C-P;

• (54) 2C-T-2;

• (55) 2C-T-4;

• (56) 2NE1;

• (57) 25I-NBOMe;

• (58) 2,5-Dimethoxy-4-chloroamphetamine (DOC);

• (59) 4-methylmethcathinone {also known as mephedrone};

• (60) 3,4-methylenedioxypyrovalerone {also known as MDPV};

• (61) 3,4-Methylenedioxymethcathinone {also known as methylone};

• (62) 4-methoxymethcathinone;

• (63) 4-Methyl-alpha-pyrrolidinopropiophenone;

• (64) 4-Methylethcathinone;

• (65) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;

• (66) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;

• (67) 5-Iodo-2-aminoindane (5-IAI);

• (68) 5-MeO-DALT;

• (69) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;

• (70) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and

• (71) 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.

Amended by Chapter 23, 2014 General Session